ストックスクリーナーアプリを入手
2.0098
2.43%
-0.0502
前日終値:
$2.06
開ける：
$2.06
24時間の取引高:
405.42K
Relative Volume:
0.19
時価総額：
$6.48M
収益：
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.0207
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-7.37%
1か月 パフォーマンス:
-33.00%
6か月 パフォーマンス:
-97.24%
1年 パフォーマンス:
-99.26%
1日の値動き範囲:
$1.97
$2.06
1週間の範囲:
$1.97
$2.26
52週間の値動き範囲:
$1.97
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
APVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
2.0098 | 6.93M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.58 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.28 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.34 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
644.68 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
304.30 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-11-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-10-05 | 再開されました | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc (APVO) 最新ニュース
Aptevo highlights prostate cancer bispecific antibody candidate By Investing.com - Investing.com Nigeria
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer - ACCESS Newswire
Aptevo's New Prostate Cancer Drug Shows Promise with Targeted Immune Response Technology - Stock Titan
Aptevo Therapeutics APVO Q2 2025 Earnings Preview Downside Risk Over Lack of Revenue Growth - AInvest
Aptevo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update | APVO Stock News - GuruFocus
Aptevo Therapeutics Inc. SEC 10-Q Report - TradingView
Aptevo Reports 85% Remission in Q2 - The Motley Fool
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update - ACCESS Newswire
Aptevo Reports Breakthrough: 85% Remission in AML Trial, Launches New Solid Tumor Program - Stock Titan
Evaluating Aptevo Therapeutics Inc. with trendline analysisReal Time Trade Execution Alert Plan - Newser
Is Aptevo Therapeutics Inc. likely to announce a buybackBest ROI Stocks This Month - sisain.net
Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionWeekly Chart Watchlist with Trade Guidance - Newser
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedRisk-Managed Swing Setup and Signal Analysis - Newser
Using data models to predict Aptevo Therapeutics Inc. stock movementSafe Entry Screening with Data Backed Analysis - Newser
Aptevo Therapeutics Inc expected to post a loss of $83.20 a shareEarnings Preview - TradingView
Aptevo Therapeutics and 60 Degrees Pharmaceuticals to be Featured on Bloomberg TV's RedChip Small Stocks, Big Money Show - AInvest
Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Corinthian
Aptevo Therapeutics (APVO) Expected to Announce Quarterly Earnings on Thursday - Defense World
Multi factor analysis applied to Aptevo Therapeutics Inc.Real Chart Based Opportunity Identification - Newser
How volatile is Aptevo Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News
What institutional investors are buying Aptevo Therapeutics Inc. stockMaximize portfolio value with timely trades - Jammu Links News
Is Aptevo Therapeutics Inc. a good long term investmentMaximize portfolio growth with expert advice - Jammu Links News
How does Aptevo Therapeutics Inc. generate profit in a changing economyDiscover undervalued stocks ready to soar - Jammu Links News
How does Aptevo Therapeutics Inc. compare to its industry peersDiscover high-impact stocks for your portfolio - Jammu Links News
Is it the right time to buy Aptevo Therapeutics Inc. stockHigh-octane financial growth - Jammu Links News
How strong is Aptevo Therapeutics Inc. company’s balance sheetBuild a portfolio for long-term financial success - Jammu Links News
Why is Aptevo Therapeutics Inc. stock attracting strong analyst attentionCapitalize on emerging growth stocks - Jammu Links News
Does Aptevo Therapeutics Inc. stock perform well during market downturnsTremendous wealth creation - Jammu Links News
When is Aptevo Therapeutics Inc. stock expected to show significant growthInvest smarter with actionable market insights - Jammu Links News
What drives Aptevo Therapeutics Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What are the latest earnings results for Aptevo Therapeutics Inc.Build a portfolio for long-term financial success - Jammu Links News
Should I hold or sell Aptevo Therapeutics Inc. stock in 2025Unlock your trading potential today - Jammu Links News
What are Aptevo Therapeutics Inc. company’s key revenue driversBuild wealth faster with consistent growth stocks - Jammu Links News
What are the technical indicators suggesting about Aptevo Therapeutics Inc.Wealth Building Trend Scanner For Smart Trading - Jammu Links News
Aptevo Therapeutics Inc. Shows Support at Fibonacci LevelFree Elite Traders Group - beatles.ru
What is Aptevo Therapeutics Inc. company’s growth strategyInvest smarter with advanced market data - Jammu Links News
Is Aptevo Therapeutics Inc. a Top Dividend Stock to Watch in 2025Top Gaining Low Risk Assets - metal.it
Is Aptevo Therapeutics Inc. a growth stock or a value stockTransform your portfolio with high-yield stocks - jammulinksnews.com
Aptevo Therapeutics Inc (APVO) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
0.22%
大文字化:
|
ボリューム (24 時間):